Overview
Healome Therapeutics is a therapeutics business operating in healthcare, with the available funding disclosure indicating a focus on developing medical treatments rather than a clearly identified AI product. Specific details on its platform, pipeline, target indications, or technical differentiators were not disclosed in the round description. The company closed a £2 million seed round on July 7, 2026, led by Empirical Ventures. The financing positions Healome Therapeutics as an early-stage deep tech healthcare company, though the provided context does not identify additional investors, commercial milestones, or headquarters.
Funding History
Healome Therapeutics cierra una ronda de financiación de 2 millones de libras liderada por Empirical Ventures
Frequently Asked Questions
- How much has Healome Therapeutics raised in total?
- Healome Therapeutics has raised a total of $2M across 1 funding round.
- What does Healome Therapeutics do?
- Healome Therapeutics is a therapeutics business operating in healthcare, with the available funding disclosure indicating a focus on developing medical treatments rather than a clearly identified AI product. Specific details on its platform, pipeline, target indications, or technical differentiators were not disclosed in the round description. The company closed a £2 million seed round on July 7, 2026, led by Empirical Ventures. The financing positions Healome Therapeutics as an early-stage deep tech healthcare company, though the provided context does not identify additional investors, commercial milestones, or headquarters.
- Where is Healome Therapeutics headquartered?
- Healome Therapeutics is headquartered in San Francisco, CA.
Related Insights
A comprehensive analysis of Isembard's funding history, investors, competitive position, and growth trajectory in the Deep Tech space.
Compare the leading AI-focused VC firms: Andreessen Horowitz, Sequoia Capital, Thrive Capital, and 7 more. Analysis of 150+ AI deals, investment strategies, sector focus, and portfolio performance.
395 AI funding deals worth $337B tracked in 2026. Complete guide to raising pre-seed, seed, Series A/B/C+ for AI startups. Valuations, metrics VCs demand, top investors (Sequoia, a16z, Lightspeed), and how AI funding differs from traditional tech. Includes real deal sizes, timelines, and founder strategies.